Status:
COMPLETED
Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus
Lead Sponsor:
Ain Shams University
Conditions:
Long Acting Insulin in Control of Gestational Diabetes Mellitus
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
PHASE3
Brief Summary
multiple dose regimen as a standard treatment for gestational diabetes will be compared to long acting insulin
Eligibility Criteria
Inclusion
- pregnant women with gestational diabetes mellitus
- between 24-28 weeks gestation
Exclusion
- other endocrinological abnormalities
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 14 2020
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT04674332
Start Date
September 1 2019
End Date
December 14 2020
Last Update
September 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Maternity Hospital
Cairo, Egypt